Invention Grant
US08691775B2 Use of drugs that activate P2Y receptors to enhance synaptogenesis
有权
使用激活P2Y受体的药物来增强突触
- Patent Title: Use of drugs that activate P2Y receptors to enhance synaptogenesis
- Patent Title (中): 使用激活P2Y受体的药物来增强突触
-
Application No.: US13090122Application Date: 2011-04-19
-
Publication No.: US08691775B2Publication Date: 2014-04-08
- Inventor: Richard Wurtman
- Applicant: Richard Wurtman
- Applicant Address: US MA Boston
- Assignee: Back Bay Scientific, LLC
- Current Assignee: Back Bay Scientific, LLC
- Current Assignee Address: US MA Boston
- Agency: Pearl Cohen Zedek Latzer Baratz LLP
- Agent Mark S. Cohen
- Main IPC: A61K31/7076
- IPC: A61K31/7076
Abstract:
The present invention encompasses compositions and methods that activate P2Y receptors for the increased production of new synapses in the central nervous system. The formulations of the invention may be administered to a healthy subject or to a subject in need thereof to restore synapses.
Public/Granted literature
- US20110257109A1 USE OF DRUGS THAT ACTIVATE P2Y RECEPTORS TO ENHANCE SYNAPTOGENESIS Public/Granted day:2011-10-20
Information query
IPC分类:
